跳至主要内容
临床试验/NCT01072565
NCT01072565已完成不适用

Optimization of SMBG Employing Modal Day Analysis: Examining Clinical Decision-making Processes Using Blinded FreeStyle Navigator Continuous Glucose Monitoring System (CGM)

HealthPartners Institute1 个研究点 分布在 1 个国家目标入组 91 人开始时间: 2010年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
91
试验地点
1
主要终点
Evaluate the efficacy of SMBG for clinical decisions related to the management of type 2 diabetes.

研究概览

简要总结

The purpose of this study is to evaluate the effectiveness of Self Monitoring of Blood Glucose (SMBG) for clinical decisions related to the management of type 2 diabetes and to determine the benefit of using Continuous Glucose Monitoring (CGM) for clinical diabetes management.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Male or female subjects ≥18 and ≤75 years of age
  • •Clinical diagnosis of diabetes
  • •Diabetes duration ≥ 1 year
  • •HbA1c ≥7.2%
  • •Diabetes can be treated with any therapy including medical nutrition therapy alone and any pharmaceutical therapy

排除标准

  • •Taken prednisone or cortisone medications in the previous 30 days
  • •Currently pregnant or planning pregnancy during the study period
  • •Presence of any severe medical or psychological condition or chronic conditions/infections that in the opinion of the Investigator would compromise the subject's safety or successful participation in the study
  • •Unable to follow the study protocol
  • •Unable to speak, read and write in English

研究组 & 干预措施

SMBG Only

Active Comparator

You will measure your blood glucose 4 times daily by finger sticks using a blood glucose meter and you will also wear a CGM device. The CGM measurements will be blinded (neither you nor the study doctor will be able to see the CGM measurements until your final study visit). Only your SMBG measurements will be considered to help manage your diabetes. Your medications will be changed or adjusted based on your HbA1c and/or glucose readings with a goal to achieve an HbA1c level of less than 7%.

干预措施: SMBG to guide clinical decisions (Other)

SMBG and CGM

Active Comparator

You will measure your blood glucose 4 times daily by finger sticks using a blood glucose meter and you will also wear a CGM device. The CGM measurements will be downloaded at each study visit and will be considered along with your SMBG measurements to help manage your diabetes. Your medications will be changed or adjusted based on your HbA1c and/or glucose readings with a goal to achieve an HbA1c level of 7%.

干预措施: SMBG and CGM (Other)

结局指标

主要结局

Evaluate the efficacy of SMBG for clinical decisions related to the management of type 2 diabetes.

时间窗: Three, six and nine months.

次要结局

  • Determine the incremental benefit of CGM for clinical decision-making.(Three, six and nine months.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验